Upgrade to SI Premium - Free Trial

BioVie Inc. (BIVI)

1.37 -0.07 (4.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/28/25 *Est.)

Latest Headlines

Form S-1 BIOVIE INC. July 17, 2026 5:21 PM - SEC Filing Form EFFECT BIOVIE INC. June 30, 2026 6:06 AM - SEC Filing Form S-3 BIOVIE INC. June 18, 2026 5:21 PM - SEC Filing Foremost Clean Energy and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV May 29, 2026 9:01 AM - StreetInsider Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2 May 27, 2026 8:00 AM - Globe NewsWire BioVie completes enrollment in long COVID treatment trial May 26, 2026 8:01 AM - StreetInsider BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID May 26, 2026 8:00 AM - Globe NewsWire BioVie completes patient visits for Parkinson's drug trial May 18, 2026 8:01 AM - StreetInsider BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease May 18, 2026 8:01 AM - Globe NewsWire Form 10-Q BIOVIE INC. For: Mar 31 May 11, 2026 4:57 PM - SEC Filing BioVie to host virtual event on bezisterim Parkinson's treatment April 27, 2026 8:00 AM - StreetInsider BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 April 27, 2026 8:00 AM - Globe NewsWire Full Article List